Organ ‐Preserving Procedures as an Option for Treatment Patients with Pancreatic Neuroendocrine Tumors

ConclusionAs the “wait‐and‐see” policy can be not useful due to uncontrolled disease progression, choice of organ‐preserving first can become the first line of decision taking in small benign pNETs. Our experience shows that organ‐preserving treatment is more comfortable for surgeon and for patient. Howe ver, it’s not universal position. The long‐term survival data still has to be estimated.

Source: Surgical Practice - December 26, 2020 Category: Surgery Authors: A.G. Kriger, S.V. Berelavichus, A.R. Kaldarov, D.S. Gorin, M.B. Raevskaya, V.V. Kazennov, V.Y. Zekster, V.I. Panteleev Tags: ORIGINAL ARTICLE Source Type: research